Skip to main content
Clinical Trials/NCT03100097
NCT03100097
Terminated
Not Applicable

A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers

Aspen Medical Products0 sites62 target enrollmentDecember 16, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Back Pain
Sponsor
Aspen Medical Products
Enrollment
62
Primary Endpoint
40% change in Oswestry Disability Index
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.

Detailed Description

The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.

Registry
clinicaltrials.gov
Start Date
December 16, 2013
End Date
December 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • o Moderate to complete disability (baseline ODI score of 21 to 80 percent)

Exclusion Criteria

  • Pregnant patients
  • Patients considering pregnancy
  • Patients in any other investigational device or drug study
  • Patients unwilling to return for follow up
  • Patients unwilling to provide access to medical claims associated with pain management.

Outcomes

Primary Outcomes

40% change in Oswestry Disability Index

Time Frame: 4 weeks

Oswestry Disability Index

Secondary Outcomes

  • Change in Opioid utilization(4 weeks, 8 weeks, 12 weeks)
  • General Health Survey(12 weeks)
  • Number of participants with treatment-related adverse events as assessed by questionnaire(4 weeks, 8 weeks, 12 weeks)

Similar Trials